These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 3471320
1. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line. Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG. Cancer Res; 1987 Jun 01; 47(11):2950-4. PubMed ID: 3471320 [Abstract] [Full Text] [Related]
2. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line. Levine AE, Black B, Brattain MG. J Cell Physiol; 1989 Mar 01; 138(3):459-66. PubMed ID: 2925796 [Abstract] [Full Text] [Related]
3. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. Mulder KM, Ramey MK, Hoosein NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG. Cancer Res; 1988 Dec 15; 48(24 Pt 1):7120-5. PubMed ID: 3191488 [Abstract] [Full Text] [Related]
4. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S, Tobon A, Varani J, Brattain MG. Cancer Res; 1988 Jul 15; 48(14):4059-64. PubMed ID: 3289738 [Abstract] [Full Text] [Related]
5. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA, Ziober BL, Morris SL, Mulder KM. Cell Growth Differ; 1993 Aug 15; 4(8):637-45. PubMed ID: 8398905 [Abstract] [Full Text] [Related]
6. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J. Cancer Res; 1989 Apr 15; 49(8):2112-7. PubMed ID: 2539253 [Abstract] [Full Text] [Related]
9. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines. Hébert CD, Birnbaum LS. Cancer Res; 1989 Jun 15; 49(12):3196-202. PubMed ID: 2541899 [Abstract] [Full Text] [Related]
10. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Hafez MM, Infante D, Winawer S, Friedman E. Cell Growth Differ; 1990 Dec 15; 1(12):617-26. PubMed ID: 2288877 [Abstract] [Full Text] [Related]
11. Purification and biological properties of type beta transforming growth factor from mouse transformed cells. Fernandez-Pol JA, Klos DJ, Grant GA. Cancer Res; 1986 Oct 15; 46(10):5153-61. PubMed ID: 3489522 [Abstract] [Full Text] [Related]
12. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms. Zhou GH, Sechrist GL, Brattain MG, Mulder KM. J Cell Physiol; 1995 Dec 15; 165(3):512-20. PubMed ID: 7593230 [Abstract] [Full Text] [Related]
13. Production of transforming growth factors by human colon cancer lines. Coffey RJ, Shipley GD, Moses HL. Cancer Res; 1986 Mar 15; 46(3):1164-9. PubMed ID: 3002610 [Abstract] [Full Text] [Related]
15. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. Levine AE, McRae LJ, Hamilton DA, Brattain DE, Yeoman LC, Brattain MG. Cancer Res; 1985 May 15; 45(5):2248-54. PubMed ID: 3857117 [Abstract] [Full Text] [Related]
17. Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material. Boyd D, Florent G, Chakrabarty S, Brattain D, Brattain MG. Cancer Res; 1988 May 15; 48(10):2825-31. PubMed ID: 3162826 [Abstract] [Full Text] [Related]